ATHE

Alterity Therapeutics
ATHE

Overview Fund Activity

29 hedge funds and large institutions have $3.36M invested in Alterity Therapeutics in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
+6
Holders Change %
+26.09%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
7
Reduced
5
Closed
7
Calls
$6.4M
Puts
$2.68M
Net Calls
+$3.73M
Net Calls Change
+$2.58M

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$706K
2
Citadel Advisors
2
Citadel Advisors
Florida
$335K
3
AG
3
Aperio Group
California
$303K
4
Barclays
4
Barclays
United Kingdom
$232K
5
Group One Trading
5
Group One Trading
Illinois
$207K

Top Sellers

1
FC
1
FIC Capital
New York
$0
2
Millennium Management
2
Millennium Management
New York
$0
3
FIM
3
Freedom Investment Management
Connecticut
$0
4
Jane Street
4
Jane Street
New York
$178K
5
CAM
5
Columbia Asset Management
Michigan
$171K
Name Holding Trade Value Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
$4K -$4K -25 -50%
CG
27
Colony Group
Massachusetts
$4K – – –
FC
28
FIC Capital
New York
– -$533K -1,268 Closed
Millennium Management
29
Millennium Management
New York
– -$277K -658 Closed
FIM
30
Freedom Investment Management
Connecticut
– -$194K -462 Closed
CS
31
Credit Suisse
Switzerland
– -$74K -176 Closed
Verition Fund Management
32
Verition Fund Management
Connecticut
– -$71K -168 Closed
TRCT
33
Tower Research Capital (TRC)
New York
– -$20K -47 Closed
Creative Planning
34
Creative Planning
Kansas
– -$6K -13 Closed
1
2